Update: Medicare Advantage Prior Authorization
A review of Medicare Advantage prior authorization, what federal oversight has changed, and why operators still face administrative and revenue risk now.
Congress
Fee for Service vs Value Based Care
Fee for service vs value based care changes who carries risk, how providers are paid, and what senior care leaders must build for the next cycle of care.
Update on Medicare Site-Neutral Payments
A guide to Medicare site-neutral payments for healthcare leaders: the policy, financial exposure, and operating decisions that could reshape care delivery.
7 Top Healthcare Policy Risks 2026
A sharp look at top healthcare policy risks 2026, from Medicare cuts and MA scrutiny to labor, oversight, and capital pressure.
Healthcare Economics Trends 2026
Healthcare economics trends 2026 will reshape reimbursement, labor, capital, and care delivery. Here’s what operators and investors should watch.
Medicare Hospice Fraud Is a Policy Failure
Medicare hospice fraud reflects weak oversight, distorted incentives, and rising compliance risk for operators, investors, and policymakers.
The Challenge of Medicare Insolvency
Medicare insolvency projections shape provider strategy, payment risk, and policy debate. Here’s what healthcare leaders should watch next.
Private Equity in Healthcare: What Changes Now
Private equity in healthcare is reshaping costs, staffing, and oversight. Here’s what operators, investors, and policymakers should watch now.
Agency Scrutiny of PE in Healthcare
My last post covered the legislative activity (Congress) concerning private equity’s role and investment in healthcare, particularly physician practices and hospitals https://rhislop3.com/legislation-restricting-pe-role-in-healthcare/ . Aside from legislation, a myriad of federal agencies are equally engaged. Federal Inquiry into Private Equity Control in Health Care In 2024, the Federal Trade Commission (FTC), the Department of Justice’s Antitrust … Read more
Legislation Restricting PE Role in Healthcare
A few weeks back, I wrote a post on the growing scrutiny private equity is receiving regarding ownership and investment in healthcare companies. That post is here Private Equity Ownership Scrutiny – Reg’s Blog At the end of that post, I mentioned a follow-up piece on the legislative efforts ongoing at the Federal level, focused … Read more